RKDA Arcadia Biosciences, Inc.
Basic Materials$0.91-0.63%ClosedMarket Cap: $1.4M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.44
P/S
0.30
EV/EBITDA
-0.05
DCF Value
$-51.86
FCF Yield
-298.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
34.5%
Operating Margin
-200.8%
Net Margin
-195.9%
ROE
-219.4%
ROA
-175.1%
ROIC
-241.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.1M | 36.4% | $-779.0K | $-4.4M | $— | — |
| Q4 null | $901.0K | 21.3% | $-1.4M | $-1.3M | $— | — |
| FY null | $4.9M | 36.2% | $-10.0M | $-2.3M | $— | — |
| Q3 null | $1.3M | 32.1% | $-1.4M | $856.0K | $— | — |
| Q2 null | $1.5M | 43.4% | $-6.0M | $-4.5M | $— | — |
| Q1 null | $1.2M | 43.2% | $-1.2M | $2.6M | $— | — |
| Q4 null | $1.2M | 32.0% | $-2.3M | $-4.1M | $— | — |
| FY null | $5.0M | 41.3% | $-3.6M | $-7.0M | $— | — |
| Q3 null | $1.5M | 32.9% | $-1.8M | $-1.6M | $— | — |
| Q2 null | $1.3M | 51.5% | $2.0M | $1.1M | $— | — |
| Q1 null | $987.0K | 52.3% | $-1.6M | $-2.4M | $— | — |
| Q4 2023 | $1.2M | 42.7% | $-3.4M | $-2.9M | $-2.22 | — |